Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs...read more
TRACON Pharmaceuticals, a biotech developing combination therapies with VEGF inhibitors to treat cancers, raised $36 million by offering 3.6 million shares at $10, well below the $12 to $14 range. The company also sold 500,000 shares at the offer price to...read more
Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the...read more
TRACON Pharmaceuticals, which is developing antibodies to treat cancer, AMD and fibrotic diseases, announced terms for its IPO on Tuesday. The San Diego, CA-based company plans to raise $47 million by offering 3.6 million shares at a price range of $12 to $14....read more
US IPO Weekly Recap: Shake Shack and Spark spike over 100% in a week with 10 IPOs
Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs...read more
TRACON Pharmaceuticals prices IPO at $10, well below $12-$14 range
TRACON Pharmaceuticals, a biotech developing combination therapies with VEGF inhibitors to treat cancers, raised $36 million by offering 3.6 million shares at $10, well below the $12 to $14 range. The company also sold 500,000 shares at the offer price to...read more
Week ahead: IPO market gains momentum with 12 deals including Shake Shack and health care
Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the...read more
Cancer biotech TRACON Pharmaceuticals sets terms for $47 million IPO
TRACON Pharmaceuticals, which is developing antibodies to treat cancer, AMD and fibrotic diseases, announced terms for its IPO on Tuesday. The San Diego, CA-based company plans to raise $47 million by offering 3.6 million shares at a price range of $12 to $14....read more